News Releases

Otsuka Pharmaceutical Co., Ltd.

June 8, 2017

Pharmaceuticals

Quick NaviTM–Mycoplasma Diagnostic Kit to Launch in Japan

  • Quick NaviTM–Mycoplasma Diagnostic Kit to be launched as a new product of the Quick Navi Series
  • As with other products of the series, this simple-to-use diagnostic kit is rapid and displays the result clearly
  • Has excellent sensitivity and specificity to mycoplasma antigen.

Otsuka Pharmaceutical Co., Ltd. will commence sales in Japan from July 12, 2017, of the diagnostic test kit Quick NaviTM–Mycoplasma. The kit, which can detect mycoplasma antigens quickly and with high sensitivity, is a new product in the Quick Navi Series of in vitro diagnostics.


Information in this news release was current as of the original release date.